We are live on !
Find out more
PAP
Persistent Asset Partners Portfolio holdings
AUM
$335M
Turnover
79.96%
1-Year Est. Return
275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
(+25%)
Cap. Flow
-$37.3M
Cap. Flow % of AUM
Cap. Flow %
-11.13%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$16M |
| 2 |
STMicroelectronics
STM
|
+$13.6M |
| 3 |
Amphenol
APH
|
+$10.9M |
| 4 |
Seagate
STX
|
+$7.07M |
| 5 |
Ford
F
|
+$6.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$18.4M |
| 2 |
Lumentum
LITE
|
+$14.5M |
| 3 |
AXT Inc
AXTI
|
+$13.3M |
| 4 |
Tower Semiconductor
TSEM
|
+$11.9M |
| 5 |
Micron Technology
MU
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.35% |
| 2 | Healthcare | 29.66% |
| 3 | Financials | 6.33% |
| 4 | Miscellaneous | 6.14% |
| 5 | Consumer Discretionary | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Outfront Media
OUT
$5.45B
| $182K | 0.05% |
+5,553
| New | +$172K |
2026 Q2
0 quarters
|
|
227
Madison Square Garden
MSGE
$3.75B
| $177K | 0.05% |
+2,186
| New | +$149K |
2026 Q2
0 quarters
|
|
228
Brinker International
EAT
$8.23B
| $175K | 0.05% |
+1,044
| New | +$154K |
2026 Q2
0 quarters
|
|
229
CALL
Intellia Therapeutics
NTLA
$1.66B
| $172K | 0.05% |
512
-28
| -5% | -$392 |
2025 Q3
3 quarters
|
|
230
New Oriental
EDU
$9.5B
| $172K | 0.05% |
3,737
-219
| -6% | -$11.1K |
2025 Q3
3 quarters
|
|
231
Hilton Worldwide
HLT
$80.8B
| $172K | 0.05% |
+519
| New | +$171K |
2026 Q2
0 quarters
|
|
232
PepGen
PEPG
$199M
| $171K | 0.05% |
95,003
+56,851
| +149% | +$92.4K |
2026 Q1
1 quarter
|
|
233
Cerebras Systems
CBRS
$29.1B
| $171K | 0.05% |
+773
| New | +$182K |
2026 Q2
0 quarters
|
|
234
MINISO
MNSO
$2.98B
| $170K | 0.05% |
14,123
-20,400
| -59% | -$287K |
2025 Q3
3 quarters
|
|
235
Pelthos Therapeutics
PTHS
$79M
| $170K | 0.05% |
6,007
| – | – |
2025 Q3
3 quarters
|
|
236
TKO Group
TKO
$13.1B
| $169K | 0.05% |
+841
| New | +$164K |
2026 Q2
0 quarters
|
|
237
Harrow
HROW
$1.08B
| $169K | 0.05% |
+3,986
| New | +$148K |
2026 Q2
0 quarters
|
|
238
CALL
Biogen
BIIB
$36B
| $169K | 0.05% |
+154
| New | +$29.5K |
2026 Q2
0 quarters
|
|
239
Compass Pathways
CMPS
$1.64B
| $168K | 0.05% |
11,845
+3,785
| +47% | +$38.4K |
2025 Q4
2 quarters
|
|
240
Benitec Biopharma
BNTC
$322M
| $167K | 0.05% |
12,493
-5,814
| -32% | -$69K |
2025 Q4
2 quarters
|
|
241
Silence Therapeutics
SLN
$1.22B
| $167K | 0.05% |
+15,170
| New | +$107K |
2026 Q2
0 quarters
|
|
242
Take-Two Interactive
TTWO
$38.4B
| $164K | 0.05% |
+655
| New | +$145K |
2026 Q2
0 quarters
|
|
243
LB Pharmaceuticals
LBRX
$1.32B
| $160K | 0.05% |
+4,926
| New | +$145K |
2026 Q2
0 quarters
|
|
244
Abeona Therapeutics
ABEO
$260M
| $159K | 0.05% |
+25,745
| New | +$141K |
2026 Q2
0 quarters
|
|
245
PUT
Incyte
INCY
$23.7B
| $159K | 0.05% |
266
| – | – |
2025 Q4
2 quarters
|
|
246
First Tracks Biotherapeutics
TRAX
$1.43B
| $159K | 0.05% |
+7,903
| New | +$148K |
2026 Q2
0 quarters
|
|
247
Amazon
AMZN
$2.84T
| $158K | 0.05% |
+665
| New | +$167K |
2026 Q2
0 quarters
|
|
248
Dauch Corp
DCH
$1.16B
| $155K | 0.05% |
+28,651
| New | +$174K |
2026 Q2
0 quarters
|
|
249
Aeva Technologies
AEVA
$719M
| $153K | 0.05% |
+5,325
| New | +$105K |
2026 Q2
0 quarters
|
|
250
Pasithea Therapeutics
KTTA
$13.7M
| $150K | 0.04% |
290,555
| – | – |
2025 Q4
2 quarters
|
|
Similar funds
PI
TFA
SIM
OWM
SS
BIA
TODC
RLIM
Persistent Asset Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.
- Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
- Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
- Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
- Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
- Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
- Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
- Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.